Literature DB >> 26063655

Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.

Hai-Jeon Yoon1, Yemi Kim2, Bom Sahn Kim3,4.   

Abstract

OBJECTIVES: This study investigated whether texture-based imaging parameters could identify invasive components of ductal carcinoma in situ (DCIS).
METHODS: We enrolled 65 biopsy-confirmed DCIS patients (62 unilateral, 3 bilateral) who underwent (18) F-FDG PET, diffusion-weighted imaging (DWI), or breast-specific gamma imaging (BSGI). We measured SUV max and intratumoral metabolic heterogeneity by the area under the curve (AUC) of cumulative SUV histograms (CSH) on PET, tumour-to-normal ratio (TNR) and coefficient of variation (COV) as an index of heterogeneity on BSGI, minimum ADC (ADC min ) and ADC difference (ADC diff ) as an index of heterogeneity on DWI. After surgery, final pathology was categorized as pure-DCIS (DCIS-P), DCIS with microinvasion (DCIS-MI), or invasive ductal carcinoma (IDC). Clinicopathologic features of DCIS were correlated with final classification.
RESULTS: Final pathology confirmed 44 DCIS-P, 14 DCIS-MI, and 10 IDC. The invasive component of DCIS was significantly correlated with higher SUV max (p = 0.017) and lower AUC-CSH (p < 0.001) on PET, higher TNR (p = 0.008) and COV (p = 0.035) on BSGI, lower ADC min (p = 0.016) and higher ADC diff (p = 0.009) on DWI, and larger pathologic size (p = 0.018). On multiple regression analysis, AUC-CSH was the only significant predictor of invasive components (p = 0.044).
CONCLUSIONS: The intratumoral metabolic heterogeneity of (18) F-FDG PET was the most important predictor of invasive components of DCIS. KEY POINTS: • Preoperative identification of invasion in DCIS is important for axillary nodal management • Higher SUV max and lower AUC-CSH from FDG PET may indicate invasive components of DCIS • Higher TNR and COV from BSGI may indicate invasive components of DCIS • Lower ADC min and higher ADC diff from DWI may indicate invasive components of DCIS • AUC-CSH, an index of metabolic heterogeneity, is an independent predictor for invasive components.

Entities:  

Keywords:  Breast-specific gamma imaging; DCIS; Diffusion magnetic resonance imaging; Invasive carcinoma; Positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 26063655     DOI: 10.1007/s00330-015-3761-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  MRI of the breast in patients with DCIS to exclude the presence of invasive disease.

Authors:  Eline E Deurloo; Jincey D Sriram; Hendrik J Teertstra; Claudette E Loo; Jelle Wesseling; Emiel J Th Rutgers; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

2.  The evolving role of PET/CT in breast cancer.

Authors:  David Groheux; Sylvie Giacchetti; Domenico Rubello; Adil Al-Nahhas; Jean-Luc Moretti; Marc Espié; Elif Hindié
Journal:  Nucl Med Commun       Date:  2010-04       Impact factor: 1.690

3.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Authors:  Naoko Mori; Hideki Ota; Shunji Mugikura; Chiaki Takasawa; Junya Tominaga; Takanori Ishida; Mika Watanabe; Kei Takase; Shoki Takahashi
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

4.  Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.

Authors:  Tadashi Watabe; Mitsuaki Tatsumi; Hiroshi Watabe; Kayako Isohashi; Hiroki Kato; Masahiro Yanagawa; Eku Shimosegawa; Jun Hatazawa
Journal:  Ann Nucl Med       Date:  2011-12-21       Impact factor: 2.668

5.  Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.

Authors:  Mary F Dillon; Enda W McDermott; Cecily M Quinn; Ann O'Doherty; Niall O'Higgins; Arnold D K Hill
Journal:  J Surg Oncol       Date:  2006-06-01       Impact factor: 3.454

Review 6.  Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.

Authors:  B Ansari; S A Ogston; C A Purdie; D J Adamson; D C Brown; A M Thompson
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939

Review 7.  Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis.

Authors:  Yu Sun; Wei Wei; Hua-Wei Yang; Jian-Lun Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

8.  Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.

Authors:  Hideo Shigematsu; Takayuki Kadoya; Norio Masumoto; Kazuo Matsuura; Akiko Emi; Keiko Kajitani; Ai Amioka; Morihito Okada
Journal:  Clin Breast Cancer       Date:  2014-06-02       Impact factor: 3.225

9.  Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

Authors:  Gary J R Cook; Connie Yip; Muhammad Siddique; Vicky Goh; Sugama Chicklore; Arunabha Roy; Paul Marsden; Shahreen Ahmad; David Landau
Journal:  J Nucl Med       Date:  2012-11-30       Impact factor: 10.057

Review 10.  Improving tumour heterogeneity MRI assessment with histograms.

Authors:  N Just
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

View more
  20 in total

1.  [18F]FDG PET/CT features for the molecular characterization of primary breast tumors.

Authors:  Lidija Antunovic; Francesca Gallivanone; Martina Sollini; Andrea Sagona; Alessandra Invento; Giulia Manfrinato; Margarita Kirienko; Corrado Tinterri; Arturo Chiti; Isabella Castiglioni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-15       Impact factor: 9.236

2.  PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.

Authors:  Lidija Antunovic; Rita De Sanctis; Luca Cozzi; Margarita Kirienko; Andrea Sagona; Rosalba Torrisi; Corrado Tinterri; Armando Santoro; Arturo Chiti; Renata Zelic; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-26       Impact factor: 9.236

Review 3.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

4.  A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules.

Authors:  TingDan Hu; ShengPing Wang; Lv Huang; JiaZhou Wang; DeBing Shi; Yuan Li; Tong Tong; Weijun Peng
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

Review 5.  Radiomics in Oncological PET/CT: Clinical Applications.

Authors:  Jeong Won Lee; Sang Mi Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-10-20

6.  Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.

Authors:  Yuhao Dong; Qianjin Feng; Wei Yang; Zixiao Lu; Chunyan Deng; Lu Zhang; Zhouyang Lian; Jing Liu; Xiaoning Luo; Shufang Pei; Xiaokai Mo; Wenhui Huang; Changhong Liang; Bin Zhang; Shuixing Zhang
Journal:  Eur Radiol       Date:  2017-08-21       Impact factor: 5.315

7.  Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma.

Authors:  Jonghoon Kim; Seong-Yoon Ryu; Seung-Hak Lee; Ho Yun Lee; Hyunjin Park
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

8.  Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Authors:  Lucía Graña-López; Michel Herranz; Inés Domínguez-Prado; Sonia Argibay; Ángeles Villares; Manuel Vázquez-Caruncho
Journal:  Eur Radiol       Date:  2019-08-02       Impact factor: 5.315

9.  Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.

Authors:  Michiro Sasaki; Mitsuhiro Tozaki; Kazunori Kubota; Wakana Murakami; Daisuke Yotsumoto; Yasuaki Sagara; Yasuyo Ohi; Shunichi Oosako; Yoshiaki Sagara
Journal:  Jpn J Radiol       Date:  2017-11-20       Impact factor: 2.374

10.  Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yo Oguma; Minami Hirasawa; Satoko Sato; Kei Takase
Journal:  Breast Cancer       Date:  2021-04-26       Impact factor: 4.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.